Slide 1: Chart Industries, Inc. Piper Jaffray August 14, 2014
Chart Industries, Inc. Piper Jaffray August 14, 2014 © 2014 Chart Industries, Inc. Exhibit 99.1
Slide 2: Disclosure: Forward-Looking Statements
Disclosure © 2014 Chart Industries, Inc. Forward-Looking Statements: This presentation includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. The use of words such as “may”, “might”, “should”, “will”, “expect”, “plan”, “anticipate”, “believe
Slide 3: Company Overview
Company Overview Asia 33% U.S. 41% Americas (Non-US) 7% RoW 3% Europe 16% FY 2013 Sales by Segment Energy 53% BioMedical 23% General Industrial 24% FY 2013 Sales by Region FY 2013 Sales by End-User Energy & Chemicals 27% Distribution & Storage 50% BioMedical 23% © 2014 Chart Industries, Inc. Techn
Slide 4: Energy & Chemicals (E&C) Overview
Energy & Chemicals (E&C) Overview © 2014 Chart Industries, Inc. Middle East 6% Natural Gas Processing 51% Air Separation 9% FY 2013 Sales by Industry Segment / Region Highlights Technology leader – providing heat exchangers and cold boxes critical to LNG, Olefin petrochemicals, natural gas process
Slide 5: Distribution & Storage (D&S) Overview
Distribution & Storage (D&S) Overview © 2014 Chart Industries, Inc. FY 2013 Sales by Industry Segment / Region Highlights Balanced customer base – 51% of segment sales derived from products used in energy applications, including LNG Strategic footprint – manufacturing located near growing end ma
Slide 6: BioMedical Overview
BioMedical Overview © 2014 Chart Industries, Inc. FY 2013 Sales by Industry Segment / Region Highlights Increase in oxygen respiratory therapy expected, once impact of Medicare competitive bidding process on U.S. market consolidation is complete Life science based research expected to increase,
Slide 7: Global Manufacturing
Global Manufacturing © 2014 Chart Industries, Inc. Operating leverage provides the flexibility to expand and reduce capacity as needed Major manufacturing locations include: North America - Georgia and Minnesota for D&S and BioMedical; also New York for BioMedical; Wisconsin, Louisiana and Okl
Slide 8: Benefits of Using Natural Gas
Benefits of Using Natural Gas Crude oil / natural gas spread continues to be significant in U.S. Lower expected costs for a range of energy consumers The cleanest fossil fuel About ½ of CO2 emissions vs. coal Power gen. produces minimal sulfur oxides and particulates Ample reserves both
Slide 9: LNG Value Chain
LNG Value Chain Uniquely positioned to address the entire LNG Value Chain – liquefaction, distribution, storage and end-use – Chart brings many years of experience in LNG solutions to our customers, facilitating the use of a clean-burning, safe fuel alternative to diesel into the future. Pre-treat
Slide 10: Historical Revenue Trends
Historical Revenue Trends © 2014 Chart Industries, Inc. 266 269 390 476 593 138 324 319 215199148 205+28% 2013 $1,177 2012 $1,014 2011 $795 2010 $555 2013 +115% $307 2012 $162 2011 $54 2010 $31 BioMed E&C D&S LNG Sales ($MM) Consolidated Sales ($MM) 26% 16% 7% 6% LNG % of Total Revenue CAGR CAGR Cha
Slide 11: Historical Orders and Backlog
Historical Orders and Backlog © 2014 Chart Industries, Inc. 0 50 100 150 200 250 300 350 400 450 500 550 600 650 700 750 Q3 12 Q1 12 Q1 13 Q1 11 Q3 10 Q3 13 Q1 14 Q3 11 E&C BioMed D&S 0 50 100 150 200 250 300 350 400 450 500 550 600 650 700 750 Q1 14 Q1 13 Q1 12 Q3 13 Q3 11 Q3 10 Q1 11 Q3 12 Quarter
Slide 12: Summary of Investment Highlights
Summary of Investment Highlights © 2014 Chart Industries, Inc. Attractive industry with long-term customer relationships Solid platform with worldwide presence and leading industry positions in all segments Solid organic earnings should provide substantial free cash flow and good liquidity P
Slide 13: www.chartindustries.com
© 2014 Chart Industries, Inc. www.chartindustries.com